Rajat Kalra, MBCHB

Rajat Kalra practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Rajat Kalra's NPI, 1346680188, was assigned on June 25, 2013. Rajat Kalra graduated from Birmingham Medical College in 2011. Rajat Kalra holds Minnesota license 67676.

Rajat Kalra's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Rajat Kalra's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. Rajat Kalra is also affiliated with Fairview Range Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Rajat Kalra to 1 more hospital, 10 medical groups, 1 dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rajat Kalra practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Rajat Kalra's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Rajat Kalra is licensed in Minnesota.

CMS data shows 457 Medicare services from Rajat Kalra across 14 procedure codes in 2024, for 380 Medicare patients. Medicare paid $28,624 for them.

CMS counts 380 Medicare patients who saw Rajat Kalra in 2024. The largest group is 65 to 74, with 167 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Rajat Kalra's median patient age at 60, with 44% women.

In 2024, Rajat Kalra wrote 593 Medicare Part D claims for 123 patients. 86% of them were for generic drugs. CMS names the drug for 466 of them, across 13 drugs with 11 or more claims each, at $70,284 in total drug cost. In 2023, CMS named 365 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Rajat Kalra for performance year 2024, reported as part of a group. Rajat Kalra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Rajat Kalra as offering telehealth.

Dmand AI links 111 papers to Rajat Kalra, published from 2014 to 2025. 2020 was the busiest year, with 20. The most frequent topics are Cardiopulmonary Resuscitation, Out-of-Hospital Cardiac Arrest and Extracorporeal Membrane Oxygenation. Rajat Kalra has published most often in Resuscitation. Rajat Kalra's most frequent co-authors are Pankaj Arora, MD, Garima Arora, MD and Jason Alan Bartos, MD.

CMS Open Payments shows 11 general payments to Rajat Kalra from 3 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $329.

Rajat Kalra graduated from Birmingham Medical College in 2011.